Incidence of Testicular Cancer in the United States, 1999-2004

被引:23
作者
Townsend, Julie S. [1 ]
Richardson, Lisa C. [1 ]
German, Robert R. [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30341 USA
关键词
testicular cancer; public health; epidemiology; incidence; health status disparities; GERM-CELL TUMORS; INCREASING INCIDENCE; INSURANCE STATUS; RISK; TRENDS; POPULATIONS; ASSOCIATION; DIAGNOSIS; ETHNICITY;
D O I
10.1177/1557988309356101
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Testicular cancer is rare but primarily affects young men. To characterize the current incidence of testicular cancer in the United States, U. S. Cancer Statistics data from 1999 through 2004 were examined. Age-adjusted (2000 U. S. standard) incidence rates were calculated for seminoma and nonseminoma testicular germ cell tumors (TGCTs). Hispanic men had the largest increase in incidence rates for nonseminomas, followed by non-Hispanic White men (annual percentage change of 3.2% and 1.9%, respectively, p < .05). Nonseminomas peaked at a younger age for Hispanic, American Indian/Alaska Native (AIAN), and Asian/Pacific Islander (API) men. Whereas 9.6% of TGCTs were diagnosed at a distant stage in non-Hispanic White men, more Hispanic (16.1%), Black (13.8%), AIAN (16.8%), and API (14.9%) men with TGCTs were diagnosed with distant stage. Monitoring incidence rates for rare cancers by race/ethnicity has improved with national population-based cancer registry coverage. Disparities in diagnosis stage have implications for effective treatment of TGCTs.
引用
收藏
页码:353 / 360
页数:8
相关论文
共 31 条
  • [1] *AM AC FAM PHYS, 2007, SUMM REC CLIN PREV S
  • [2] [Anonymous], 1999, NAT PROGR CANC REG C
  • [3] [Anonymous], 2005, BEH RISK FACT SURV S
  • [4] Biggs ML, 2004, CANCER CAUSE CONTROL, V15, P437
  • [5] Methods for improving cancer surveillance data in American Indian and Alaska Native populations
    Espey, David K.
    Wiggins, Charles L.
    Jim, Melissa A.
    Miller, Barry A.
    Johnson, Christopher J.
    Becker, Tom M.
    [J]. CANCER, 2008, 113 (05) : 1120 - 1130
  • [6] Medical treatment of advanced testicular cancer
    Feldman, Darren R.
    Bosl, George J.
    Sheinfeld, Joel
    Motzer, Robert J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (06): : 672 - 684
  • [7] Epidemiology of testicular cancer: an overview
    Garner, MJ
    Turner, MC
    Ghadirian, P
    Krewski, D
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (03) : 331 - 339
  • [8] Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis
    Halpern, Michael T.
    Ward, Elizabeth M.
    Pavluck, Alexandre L.
    Schrag, Nicole M.
    Bian, John
    Chen, Amy Y.
    [J]. LANCET ONCOLOGY, 2008, 9 (03) : 222 - 231
  • [9] Insurance status and the use of guideline therapy in the treatment of selected cancers
    Harlan, LC
    Greene, AL
    Clegg, LX
    Mooney, M
    Stevens, JL
    Brown, ML
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9079 - 9088
  • [10] Holzik M. F. L., 2004, Lancet Oncology, V5, P363, DOI 10.1016/S1470-2045(04)01493-7